Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Haemonetics (HAE) Operating Margin (2016 - 2025)

Historic Operating Margin for Haemonetics (HAE) over the last 17 years, with Q4 2025 value amounting to 19.88%.

  • Haemonetics' Operating Margin rose 29500.0% to 19.88% in Q4 2025 from the same period last year, while for Dec 2025 it was 19.05%, marking a year-over-year increase of 59100.0%. This contributed to the annual value of 16.3% for FY2025, which is 37000.0% up from last year.
  • According to the latest figures from Q4 2025, Haemonetics' Operating Margin is 19.88%, which was up 29500.0% from 17.87% recorded in Q3 2025.
  • Haemonetics' 5-year Operating Margin high stood at 21.58% for Q1 2025, and its period low was 9.41% during Q2 2021.
  • For the 5-year period, Haemonetics' Operating Margin averaged around 12.31%, with its median value being 13.7% (2022).
  • As far as peak fluctuations go, Haemonetics' Operating Margin plummeted by -203100bps in 2021, and later surged by 166500bps in 2022.
  • Quarter analysis of 5 years shows Haemonetics' Operating Margin stood at 10.22% in 2021, then soared by 39bps to 14.18% in 2022, then fell by -4bps to 13.67% in 2023, then increased by 24bps to 16.94% in 2024, then grew by 17bps to 19.88% in 2025.
  • Its last three reported values are 19.88% in Q4 2025, 17.87% for Q3 2025, and 16.76% during Q2 2025.